FSHD
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Dyne TherapeuticsWALTHAM, MA
1 programMotor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Dyne TherapeuticsMotor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Clinical Trials (1)
Total enrollment: 450 patients across 1 trials
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
Start: Dec 2020Est. completion: Jan 2028450 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 450 patients
1 companies competing in this space